Biomarkers as an opportunity to stratify for outcome in systemic sclerosis

Biomarkers as an opportunity to stratify for outcome in systemic sclerosis

Bibliographic Details
Main Authors:	Giuseppina Abignano, Francesco Del Galdo
Format:	Article
Language:	English
Published:	AVES Yayincilik 2020-10-01
Series:	European Journal of Rheumatology
Online Access:	https://www.eurjrheumatol.org/en/biomarkers-as-an-opportunity-to-stratify-for-outcome-in-systemic-sclerosis-133322

Similar Items

The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis
by: Gianluca Bagnato, et al.
Published: (2021-03-01)

Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition
by: Clarissa Corinaldesi, et al.
Published: (2021-03-01)

Hypocomplementemia in systemic sclerosis
by: G. Valentini, et al.
Published: (2011-09-01)

A special European Journal of Rheumatology issue on systemic sclerosis: What and why?
by: Francesco Del Galdo, et al.
Published: (2020-10-01)

Hypocomplementemia in systemic sclerosis- author reply
by: G. Valentini, et al.
Published: (2011-06-01)

ASCO Resource-Stratified Guidelines: Methods and Opportunities
by: Sana Al-Sukhun, et al.
Published: (2018-08-01)

Stratified Outcome Evaluation of Peritonitis
by: Wabwire B, et al.
Published: (2014-07-01)

Survival and death causes in 251 systemic sclerosis patients from a single Italian center
by: M. Iudici, et al.
Published: (2011-06-01)

Salivary Biomarkers in Systemic Sclerosis Disease
by: Zeineb Zian, et al.
Published: (2018-01-01)

The search for new biomarkers in systemic sclerosis
by: Cristiane Kayser

Biomarkers in the stratified water column of the Landsort Deep (Baltic Sea)
by: C. Berndmeyer, et al.
Published: (2014-12-01)

Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts
by: Christopher W. Wasson, et al.
Published: (2020-12-01)

The Peripheral Nervous System in Amyotrophic Lateral Sclerosis: Opportunities for Translational Research
by: Francesco Gentile, et al.
Published: (2019-06-01)

Biomarkers in Multiple Sclerosis
by: Roland Martin, et al.
Published: (2006-01-01)

Equalizing Opportunity by Stratifying Education? Intergenerational Mobility in Germany across Institution Types
by: Axxe, Erick
Published: (2019)

Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
by: Lafyatis R
Published: (2010-11-01)

Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
by: Harpreet K. Lota, et al.
Published: (2012-01-01)

Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans
by: Meghan J. Chenoweth, et al.
Published: (2021-10-01)

Stratified and Stratifying Differentiation of Tourism in Taiwan
by: Liu, Yi-Lin, et al.
Published: (2003)

Molecular biomarkers in multiple sclerosis
by: Tjalf Ziemssen, et al.
Published: (2019-12-01)

Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.
by: Sarah A Pendergrass, et al.
Published: (2010-08-01)

Interfacial behaviour in stratified and stratifying annular flows
by: Lecoeur, Nora
Published: (2013)

Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications
by: Malottki Kinga, et al.
Published: (2011-12-01)

Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics
by: Quincy A. Hathaway, et al.
Published: (2019-06-01)

A blood-based biomarker panel to risk-stratify mild traumatic brain injury.
by: Richa Sharma, et al.
Published: (2017-01-01)

Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update
by: Akira Utsunomiya, et al.
Published: (2020-10-01)

Additive Value of Biomarkers and Echocardiography to Stratify the Risk of Death in Heart Failure Patients with Reduced Ejection Fraction
by: Calogero Falletta, et al.
Published: (2019-01-01)

Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
by: Qian Sun, et al.
Published: (2020-06-01)

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
by: Camelia Frantz, et al.
Published: (2018-01-01)

The role of biomarkers in the diagnosis of Multiple Sclerosis
by: Gustavo Miguel da Rocha Rodrigues
Published: (2019)

Biomarkers of brain plasticity in multiple sclerosis
by: Marta Milewska-Jędrzejczak, et al.
Published: (2019-05-01)

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
by: Siobhan E. Kirk, et al.
Published: (2019-03-01)

Proteomic Techniques as Biomarkers for Multiple Sclerosis
by: J Gordon Millichap
Published: (2012-06-01)

Biomarkers in Multiple Sclerosis: Role of Antibodies
by: Thomas Berger, et al.
Published: (2006-01-01)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
by: Gavin Giovannoni
Published: (2006-01-01)

Chemokine Receptors as Biomarkers in Multiple Sclerosis
by: Robert J. Fox, et al.
Published: (2006-01-01)

Lipid Biomarkers for Amyotrophic Lateral Sclerosis
by: Jose-Luis González De Aguilar, et al.
Published: (2019-04-01)

Inflammasome Proteins As Biomarkers of Multiple Sclerosis
by: Robert W. Keane, et al.
Published: (2018-03-01)

Functional Biomarkers for Amyotrophic Lateral Sclerosis
by: William Huynh, et al.
Published: (2019-01-01)

Longitudinal biomarkers in amyotrophic lateral sclerosis
by: Fen Huang, et al.
Published: (2020-07-01)